News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Alessandro Di Federico: Lovely days at ASCO2024
Photo from Alessandro Di Federico/X
Jun 9, 2024, 16:53

Alessandro Di Federico: Lovely days at ASCO2024

Alessandro Di Federico, Medical Oncologist and PhD student at University of Bologna, shared a post on X:

“Lovely days at ASCO2024 with cutting-edge science, many talented friends, and my terrific mentors Mark Awad and Professor Andrea Ardizzoni.

They still have to teach me how to look at the camera though!

P.S. check out our study on TTF-1 expression in LUAD.”

Proceed to the article.
Source: Alessandro Di Federico/X

Alessandro Di Federico Andrea Ardizzoni ASCO ASCO24 cancer LUAD lung adenocarcinoma Mark Awad OncoDaily Oncology TTF-1 TTF-1 expression in LUAD
Special Coverage
Blog
Jan 31, 2025, 22:43
Yakup Ergün: External-beam radiation versus TACE for HCC
Blog
Jan 31, 2025, 22:43
Mark Lewis: Running, walking, and crawling are all moving forward, just at different speeds
Insight
Jan 31, 2025, 22:43
Issa Mohamad: Survey of Current Practices for Early-Stage Glottic Squamous Cell Carcinoma
Blog
Jan 31, 2025, 22:43
Monika Pansari: Early detection saves lives
Blog
Jan 31, 2025, 22:43
Bhavin Vadodariya: Team work in cancer surgery
Blog
Jan 31, 2025, 22:43
Europe, the time is now: Liver health can’t wait - ELPA
Blog
Jan 31, 2025, 22:43
Wafaa Rashed: Honored to feature Catherine Metayer in this episode of the PAPERI Bright Minds Series
Blog
Jan 31, 2025, 22:43
The first outreach of the year took us to Stem Child Care Academy - Medicaid Cancer Foundation
Blog
Jan 31, 2025, 22:43
Olubukola Ayodele: Thankful to participate in the Cancer Symposium at the University of Leicester
Blog
Jan 31, 2025, 22:42
Transcriptional States and Dynamics of Circulating Tumor-Infiltrating Lymphocytes during Immunotherapy
Insight
Jan 31, 2025, 19:25
Tanja Obradovic: New Phase III trial with an innovative MOA may soon change the standard of care for second-line MSS CRC
Blog
Jan 31, 2025, 18:05
Shining a light on the EU-funded projects - Association of European Cancer Leagues